Biotech Stocks: Risky, But Worth a Peek?

Ever feel like investing is just waiting around, then suddenly—boom—something big happens? That’s biotech stocks for you. Three under-the-radar companies are making waves: UroGen’s bladder cancer drug could hit a bigger market soon, Nektar’s comeback story is turning heads after some rough years, and Verve is trying to one-and-done heart disease with gene editing. Just remember, these picks are wild rides—big wins or big waits. Would you roll the dice? #Business #Industry #InvestingTips